Tonix receives FDA approval of Tonmya (cyclobenzaprine HCl) for fibromyalgia in adults

Tonix Pharmaceuticals Holding Corp.

FDA approved Tonmya (cyclobenzaprine HCl sublingual tablets) for treatment of fibromyalgia in adults.
Product launch and commercialization strategy underway; commercial team led by Thomas Englese.
Webcast and conference call held August 18, 2025 to discuss approval and go-to-market plan.
Management presented on product label, market opportunity, and key clinical data from TNX-102 SL trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.